Technical analysis of Impact BioMedical Inc. (IBO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions.
Price Performance
| 1 month | +5.96% |
| 3 months | -0.84% |
| Year-to-date | -1.39% |
| 1 year | -21.14% |
52-Week Range
| 52-week High | $0.83 |
| 52-week Low | $0.37 |
| Avg Volume (90d) | 105K |
Technical Indicators
| SMA 50 | $0.46 |
| SMA 200 | $0.52 |
| Beta | 3.86 |
| 30-day Volatility (annualised) | 83.0% |
| Price vs SMA 50 | +9.3% |
| Price vs SMA 200 | -3.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $0.54 | |
| 2025-11 | $0.45 | -16.7% |
| 2025-12 | $0.51 | +13.2% |
| 2026-01 | $0.49 | -3.0% |
| 2026-02 | $0.44 | -11.2% |
| 2026-03 | $0.60 | +37.8% |
| 2026-04 | $0.68 | +13.3% |
| 2026-05 | $0.52 | -23.5% |
| 2026-06 | $0.46 | -11.5% |
| 2026-07 | $0.43 | -6.5% |
| 2026-08 | $0.46 | +7.2% |
| 2026-09 | $0.50 | +8.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.50 |
| Market Cap | $54M |
| Exchange | AMEX |
| Country | US |
Valuation Ratios
| Price / Book | 4.56 |
| EV / EBITDA | -132.72 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 0.16 |